Fluorescence bioimaging of drug nanocarriers based on Förster resonance energy transfer, aggregation-induced emission and aggregation-caused quenching
Acta Pharmaceutica Sinica B · 2026-04 · 16 (4) · 1991-2028
DOI: 10.1016/j.apsb.2025.10.023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-04. Verfasst von Runtong Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Fudan University, Key Laboratory of Smart Drug Delivery of MOE and National Key Laboratory of Advanced Drug Formul…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 287 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
The introduction of environment-responsive probes has greatly improved the accuracy of fluorescence bioimaging in evaluating drug nanocarriers. This review highlights the key roles of Förster resonance energy transfer, aggregation-induced emission, and aggregation-caused quenching in advancing nanomedicine. These technologies have enhanced our understanding of nanocarrier pharmacokinetics, biodistribution, and intracellular behavior, providing valuable insights for optimizing drug delivery systems. Their integration into imaging platforms has enabled precise monitoring of nanocarriers in complex biological environments. This review outlines detailed progress in the use of environment-responsive probes, emphasizing their importance in improving the design and effectiveness of nanomedicines. Looking forward, advances in probe engineering and multimodal imaging, combined with computational tools, are expected to drive the development of more targeted, efficient, and personalized therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Fudan University, Key Laboratory of Smart Drug Delivery of MOE and National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Shanghai 201203, China.
- Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.
- Fudan Zhangjiang Institute, Shanghai 201203, China.
- Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China.
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Zhang, R., He, H., Lu, Y., Raza, A., & Wu, W. (2026). Fluorescence bioimaging of drug nanocarriers based on Förster resonance energy transfer, aggregation-induced emission and aggregation-caused quenching. Acta Pharmaceutica Sinica B, 16(4), 1991-2028. https://doi.org/10.1016/j.apsb.2025.10.023
Vancouver
Zhang R, He H, Lu Y, Raza A, Wu W. Fluorescence bioimaging of drug nanocarriers based on Förster resonance energy transfer, aggregation-induced emission and aggregation-caused quenching. Acta Pharmaceutica Sinica B. 2026;16(4):1991-2028. doi:10.1016/j.apsb.2025.10.023
BibTeX
@article{Zhang2026,
author = {Zhang, Runtong and He, Haisheng and Lu, Yi and Raza, Aun and Wu, Wei},
title = {Fluorescence bioimaging of drug nanocarriers based on Förster resonance energy transfer, aggregation-induced emission and aggregation-caused quenching},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {4},
pages = {1991--2028},
doi = {10.1016/j.apsb.2025.10.023}
}
EUVIMED